EssilorLuxottica (OTCMKTS:ESLOY) Rating Increased to Buy at Kepler Capital Markets

Kepler Capital Markets upgraded shares of EssilorLuxottica (OTCMKTS:ESLOY) from a hold rating to a buy rating in a report published on Thursday morning, MarketBeat reports.

Several other equities analysts also recently issued reports on the stock. UBS Group raised shares of EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a research note on Thursday, November 27th. Zacks Research lowered EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. HSBC upgraded EssilorLuxottica from a “hold” rating to a “buy” rating in a research report on Wednesday. Citigroup restated a “buy” rating on shares of EssilorLuxottica in a research report on Thursday, December 11th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating on shares of EssilorLuxottica in a research note on Friday, December 5th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy”.

EssilorLuxottica Trading Down 0.0%

Shares of OTCMKTS ESLOY opened at $162.99 on Thursday. The company has a 50 day simple moving average of $169.59 and a 200 day simple moving average of $161.64. EssilorLuxottica has a 1 year low of $123.09 and a 1 year high of $186.81. The company has a current ratio of 0.97, a quick ratio of 0.67 and a debt-to-equity ratio of 0.18.

EssilorLuxottica Company Profile

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.